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Objectives: A comparison of glaucoma referral
refinement schemes (GRRS) in the UK during a time
period of considerable change in national policy and
guidance.
Design: Retrospective multisite review.
Setting: The outcomes of clinical examinations by
optometrists with a specialist interest in glaucoma
(OSIs) were compared with optometrists with no
specialist interest in glaucoma (non-OSIs). Data from
Huntingdon and Nottingham assessed non-OSI
findings, while Manchester and Gloucestershire
reviewed OSI findings.
Participants: 1086 patients. 434 patients were from
Huntingdon, 179 from Manchester, 204 from
Gloucestershire and 269 from Nottingham.
Results: The first-visit discharge rate (FVDR) for all
time periods for OSIs was 14.1% compared with
36.1% from non-OSIs (difference 22%, CI 16.9% to
26.7%; p<0.001). The FVDR increased after the April
2009 National Institute for Health and Clinical
Excellence (NICE) glaucoma guidelines compared with
pre-NICE, which was particularly evident when pre-
NICE was compared with the current practice time
period (OSIs 6.2–17.2%, difference 11%, CI −24.7%
to 4.3%; p=0.18, non-OSIs 29.2–43.9%, difference
14.7%, CI −27.8% to −0.30%; p=0.03). Elevated
intraocular pressure (IOP) was the commonest reason
for referral for OSIs and non-OSIs, 28.7% and 36.1%,
respectively, of total referrals. The proportion of
referrals for elevated IOP increased from 10.9% pre-
NICE to 28.0% post-NICE for OSIs, and from 19% to
45.1% for non-OSIs.
Conclusions: In terms of ‘demand management’,
OSIs can reduce FVDR of patients reviewed in
secondary care; however, in terms of ‘patient safety’
this study also shows that overemphasis on IOP as a
criterion for referral is having an adverse effect on both
the non-OSIs and indeed the OSIs ability to detect
ARTICLE SUMMARY
Article focus
▪ Can specialist trained optometrists reduce the
first-visit discharge rate of patients identified in
primary care as being at risk of glaucoma and
therefore reduce the burden on the hospital eye
service?
▪ What is the temporal trend in first-visit discharge
rates?
▪ What is a safe model of glaucoma referral refine-
ment that can be used to establish a national
framework?
Key messages
▪ Specialist trained optometrists can reduce the first-
visit discharge rate of patients subsequently
reviewed in secondary care compared with direct
referrals from non-specialist optometrists (36.1%
vs 14.1%, difference 22%, CI 16.9% to 26.7%;
p<0.001). However, in terms of ‘patient safety’ this
study also shows that the overemphasis on intrao-
cular pressure as a criterion for referral is having
an adverse effect on both the specialist and non-
specialist optometrist’s ability to detect glaucomat-
ous optic nerve features.
▪ First-visit discharge rates have increased in the
time periods post National Institute for Health
and Clinical Excellence (NICE) glaucoma guide-
line publication, and are continuing to increase,
particularly for the optometrists with no special-
ist interest in glaucoma.
▪ It is the authors’ recommendation that patients with
a high chance of being diagnosed with glaucoma
based on the examination findings of the non-
specialist optometrist should be referred directly to
secondary care and those at lower risk could effect-
ively be reviewed by a specialist trained optometrist
carrying out a comprehensive eye examination.
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glaucomatous optic nerve features. It is recommended that
referral letters from non-OSIs be stratified for risk, directing high-
risk patients straight to secondary care, and low-risk patients to
OSIs.
INTRODUCTION
Glaucoma is the world’s leading cause of irreversible
blindness.1 This progressive optic neuropathy is charac-
terised by damage to the optic nerve head and nerve
ﬁbre layer, with visual ﬁeld (VF) loss which is usually
asymptomatic until the disease becomes advanced. Up
to 20% of referrals to ophthalmology clinics in the UK
are for suspected glaucoma, with the annual cost for
monitoring patients with this chronic, and potentially
blinding condition estimated to be £22 469 000.2 3
In the UK, most referrals for suspected glaucoma are
generated through opportunistic surveillance during
sight tests by primary care optometrists (hereafter
referred to as an optometrist with no specialist interest
in glaucoma, non-OSI).3–5
As part of a sight test, the non-OSI is required to
perform an examination of the optic disc using fundu-
scopy. If clinically indicated they may measure the
intraocular pressure (IOP) typically using ‘air puff’ non-
contact tonometry (NCT) which is prone to higher vari-
ability and overestimating the IOP (in individuals with
thick corneas) compared with Goldmann contact tono-
metry used in hospital ophthalmology departments.6 VF
testing is also carried out if clinically indicated and com-
pletes the established triad of examinations/tests to
detect glaucoma.
The number of patients being referred to ophthalmol-
ogy departments is rapidly increasing due to an ageing
population, advances in diagnostic and screening tools,
such as VF testing and changes in national and profes-
sional guidance with regard to glaucoma care.
The National Institute for Health and Clinical
Excellence (NICE) guidelines for the diagnosis and
management of chronic open-angle glaucoma and
ocular hypertension (OHT; elevated IOP but no signs of
glaucomatous optic disc damage or VF loss) were
published in April 2009.7–9 These guidelines however
did not include in their remit guidance on the detection
and referral of suspected glaucoma by community opto-
metrists as it was felt this would make the guidelines
unmanageably large.10
The representative organisation for the optometry pro-
fession and individual optometrists, the Association of
Optometrists (AOP), response to these guidelines was as
follows:
English and Welsh PCTs and Health Boards may not have
the resources to cope with the numbers of referrals – many
of which, because they will have had their pressures taken
using NCT, will be false positives. Nevertheless, in the
absence of funding to repeat pressures using Goldmann,
the AOP believes strongly that optometrists have no choice
other than to refer a patient who has a sign of ocular hyper-
tension – e.g. pressures measured at over 21 mmHg, using
whatever tonometer they choose. To identify a sign of OHT
and then not to act on it could be considered to be unpro-
fessional, especially when the correct course of action has
been well researched, by a panel of experts in the ﬁeld,
using evidence-based methods, and has been ofﬁcially pub-
lished by NICE.11
Prior to this, an optometrist would use their clinical
judgement as to whether a patient with normal ocular
examination and a borderline IOP warranted referral
based on other risk factors such as age and family history.
However, after the AOP’s recommendation, many of these
patients are now being referred with a resultant surge in
the number of referrals for suspected glaucoma and, con-
sequently, an increase in ﬁrst-visit discharges.9 12–14
In December 2009, an attempt by the Royal College of
Ophthalmologists and College of Optometrists to reduce
the total number of ﬁrst-visit discharges was made by
issuing Joint College Guidance ( JCG) in relation to
patients with OHT with low risk of signiﬁcant VF loss in
their lifetime. It was recommended that optometrists con-
sider not referring patients aged over 80 years with an IOP
of less than 26 mmHg with an otherwise normal ocular
examination. For patients aged between 65 and 80 years
this IOP criterion was less than 25 mmHg, as current
NICE guidance does not recommend offering treatment
to these subsets of patients. For the latter group, it was
recommended that these individuals be reviewed annually
by a community optometrist.15 The most recent JCG, pub-
lished in March 2013, recommended introduction of
repeat IOP measurement schemes to reduce false-positive
referrals to the hospital eye service, and recommended
where possible to facilitate the implementation of glau-
coma referral reﬁnement schemes (GRRS) to further
reduce the false-positive referral rate.16
GRRS have proliferated across the country over the
past decade, often demonstrating marked variation in
pathway design, referral criteria as well as the level of
competency and training required by the participating
optometrists.17–24 This study, the largest and only multi-
site review of GRRS in the UK, aimed to investigate if
ARTICLE SUMMARY
Strengths and limitations of this study
▪ This is the first multisite review of glaucoma referral refinement
schemes in the UK.
▪ The time series for the study was carefully selected to encom-
pass all the major changes in clinical guidelines and practice
since 2009. However, by definition a retrospective observa-
tional time series study will not provide data on all time points.
▪ The false-negative rate, or percentage of patients who were
inappropriately discharged by the specialist and non-specialist
optometrists, is not known. This will be addressed in an
upcoming prospective study using the recommendations of
this report.
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specialist trained optometrists can effectively reduce the
ﬁrst-visit discharge rate (FVDR) of patients identiﬁed in
primary care as being at risk of glaucoma and therefore
reduce the burden on the hospital eye service. Using
the data from this report, a safe and efﬁcient model of
glaucoma referral reﬁnement is described that can be
used to establish a much-needed national framework for
GRRS. This study was carried out by the Department of
Health’s initiative called The North East, North Central
London and Essex Health Innovation & Education
Cluster (HIEC) Glaucoma pathway project.25
METHODS
The outcomes of GRRS in Huntingdon, Manchester,
Gloucestershire and Nottingham were retrospectively ana-
lysed during four 2-month time periods: pre-NICE (March
and up to 22 April 2009, when the guidelines were pub-
lished), post-NICE (November and December 2009),
post-JCG (August and September 2010) and current prac-
tice (March and April 2011). Ethical approval at each trust
was obtained prior to data collection.
Each scheme is organisationally distinct and reﬂects the
range of variation between schemes nationally (ﬁgure 1).
The Huntingdon, Manchester and Gloucestershire
schemes are all community based, whereas the Nottingham
scheme is hospital based. A more detailed description of
each scheme and a summary table 2 is found in an online
supplementary appendix.
Each scheme requires participating optometrists to
gain local accreditation of core optometric competen-
cies (such as Goldmann contact tonometry, slit-lamp bin-
ocular indirect ophthalmoscopy and VF interpretation)
through a hospital approved training scheme. A special-
ist qualiﬁcation in glaucoma is not a prerequisite.26–28
The inclusion criteria for Huntingdon and Nottingham
were referrals from non-OSIs as well the subsequent ﬁnd-
ings from the next eye health professional (for
Nottingham and low-risk Huntingdon patients this was the
optometrist with specialist interest in glaucoma (OSI) and
for high-risk Huntingdon patients this was a glaucoma con-
sultant). The inclusion criteria for Manchester and
Gloucestershire were referrals from OSIs and the subse-
quent hospital visit. Referrals from any other source were
excluded.
Statistical analysis
Data from electronic and paper patient records and
paper referral letters were collated using Microsoft
Excel; statistical analysis was performed in R (V.2.15.1, R
Foundation for StatisticalComputing, Vienna, Austria).
Percentages of FVDR were compared using Fisher’s
Figure 1 Schematic flow chart of the organisational structure of each of the four glaucoma referral refinement schemes. HES,
hospital eye service.
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exact test, and conﬁdence limits for the differences
between percentages were calculated using Newcombe’s
Hybrid Score Interval Method. Conﬁdence limits and p
values within a set of factor levels have been corrected
for multiplicity using the Dunn-Sidak method.
FVDR, the main outcome metric for this analysis, is
deﬁned as the percentage of referrals from an OSI or a
non-OSI that was discharged at the ﬁrst visit to the ﬁnal
provider. FVDR was chosen in preference to ‘false-
positive rate’, the chosen outcome metric in the pub-
lished literature on this topic to date, as no inference of
the appropriateness or falseness of referral is implied as
this may be governed by local policy.
Agreement rates on diagnostic accuracy and FVDR
always use the diagnosis given by the ﬁnal clinician, and
assume their ﬁndings to be the gold standard. For
Nottingham and low-risk Huntingdon this is the OSI,
and for Manchester, Gloucestershire and high-risk
Huntingdon this was the consultant ophthalmologist.
RESULTS
Data of 1086 patients (48% men, mean age 63 years)
were analysed: 190 (17.5%) pre-NICE, 338 (35.7%)
post-NICE, 287 (26.4%) post-JCG and 271 (25%) from
the current practice group; 434 (42% men, mean age
62 years) patients were from Huntingdon (304 high and
130 low risk), 179 (57% men, mean age 62 years) from
Manchester, 204 (55% men, mean age 64 years) from
Gloucestershire and 269 (46% men, mean age 62 years)
were from Nottingham.
Fifty-six percent of patients referred from OSIs were
men compared with 44% from non-OSIs. Mean age of
patients referred by the OSIs was 63 years compared
with 62 years for non-OSIs.
Reason for referral from non-OSI and OSI optometrists
The most common reason for referral by a non-OSI
across all observation periods was for an elevated IOP
only (36.1%). In the pre-NICE time frame, IOP-only
referrals accounted for 19% of referrals, which increases
to 45.1% in the post-NICE period. This was coupled
with a decrease in many other stated reasons for referral
by the non-OSI, particularly those not including IOP,
exempliﬁed by disc-only referrals, which reduced from
15.9% (20 referrals) pre-NICE to 6.1% (12 referrals)
post-NICE.
The most common reason for OSI referral across all
observation periods was also for raised IOP only
(28.8%), though a less marked increase (10.9% vs 28%)
post-NICE was observed compared with non-OSIs.
However, in terms of rate of increase for IOP only refer-
rals post-NICE, this was similar for both groups (×2.6
increase for OSIs and ×2.4 increase for non-OSIs).
FVDR associated with non-OSI and OSI optometrists
The overall FVDR for referrals by a non-OSI was 36.1%
and for OSI referrals was 14.1% (difference 22% CI 16.9%
to 26.7%, p<0.001). FVDR for combination of each site
and time period is given in table 1. When interpreting
these data it is important to note that for Nottingham and
Huntingdon, FVDR is for referrals from non-OSIs, while
for Manchester and Gloucestershire, FVDR is that of refer-
rals from OSIs.
FVDR pre-NICE was 21.9% compared with 35.4% in
the current practice time period (difference 13.5%, CI
−23.8% to −2.4%; p=0.006). For OSIs, FVDR was 6.3%
pre-NICE and 17.2% current practice (difference 11.0%,
CI −24.7% to 4.3%; p=0.18) and for non-OSIs FVDR was
29.2% pre-NICE and 43.9% current practice (difference
14.7%, CI −27.8% to −0.30%; p=0.03).
Outcomes of referrals from non-OSI and OSI optometrists
based on reason for referral
A referral for suspected glaucoma is characteristically
based on the ﬁnding of an elevated IOP, an abnormal
optic disc appearance, an abnormal VF or a combin-
ation of these ﬁndings. These patients are then classiﬁed
as either having glaucoma, a suspicion of glaucoma
(‘glaucoma suspect’) or as being normal. The largest
source of ﬁrst-visit discharges for both non-OSIs and
OSIs was for IOP-only related referrals, with 83.5% and
55% of these, respectively, being discharged. Referrals
based on more than one criterion, such as those for
abnormal IOP, optic disc and VFs, resulted in fewer ﬁrst-
visit discharges (40.8% non-OSI and 25.7% OSI). More
details are given in ﬁgure 2.
Table 1 First-visit discharge rate by site and by time period
Site
First-visit discharge rate by period
All periodsPre-NICE Post-NICE Post-JCG Current practice
Nottingham (non-OSI) 19.5 32.8 25.3 53.7 33.5
Huntingdon (non-OSI) 33.3 37.6 42.1 38.3 38.0
Mean non-OSI 29.2 35.0 34.7 43.9 36.1
Manchester (OSI) 4.9 6.5 16.9 3.0 8.9
Gloucestershire (OSI) 8.7 20.3 12.5 25.9 18.6
Mean OSI 6.3 15.2 15.0 17.2 14.1
Mean overall 21.9 27.8 27.6 35.4 28.6
JCG, Joint College Guidance; NICE, National Institute for Health and Clinical Excellence; non-OSI, optometrist with no specialist interest in
glaucoma; OSI, optometrist with specialist interest in glaucoma.
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DISCUSSION
The main rationale for the reﬁnement of referrals for
suspected glaucoma has been to reduce the overall
number of referrals to the hospital eye services while
simultaneously increasing the quality and accuracy of
the referral process.
Reason for referral from non-OSI and OSI optometrists
Both non-OSIs and OSIs demonstrated a similar trend
for the stated reasons for referral with IOP-only referrals
being the largest category for referral, 36.1% and 28.7%,
respectively, followed by referrals for elevated IOP and
abnormal optic disc, 12.8% and 19.6%, respectively.
Disc-only referrals and disc and VF referrals were the
next largest categories in both groups, with the smallest
category being for elevated IOP and a suspicious VF.
In contrast, the temporal trend observed among the
stated reasons for referral for the non-OSI and OSI
displayed marked variation. All referral categories by a
non-OSI not involving IOP as a referral criterion demon-
strated a decline post-NICE compared to pre-NICE. The
reverse was seen for referrals involving IOP, particularly
IOP-only referrals which increased from 19% (24 refer-
rals) to 45.1% (96 referrals). The AOP’s response to the
NICE guidelines seems to have had much less effect on
the temporal trend in referrals generated by OSIs.
Exceptions being IOP-only referrals which increased
2.6-fold post-NICE (10.9% pre-NICE to 28% post-NICE),
and referrals citing IOP, optic disc and VFs decreased
from 26.6% (16 referrals) to 6.4% (7 referrals). This
would suggest that, post-NICE, optometrists initiating
referrals concentrate more on IOP as a reason for refer-
ral with less emphasis being placed on concurrent assess-
ment of the optic nerve and VF.
It would seem that the introduction of JCG was suc-
cessful in reducing the proportion of referrals by a
Figure 2 The outcomes of
patients referred by optometrist
with no specialist interest in
glaucoma (non-OSIs, top) and
optometrist with specialist interest
in glaucoma (OSIs, bottom). The
width of each bar is
representative of the proportion of
the total referral base.
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non-OSI for only a raised IOP (45.1–32%) after the
large increase post-NICE. This trend was not observed in
the OSI group where the proportion of referrals for
raised IOP only actually increased from 28% to 41.5%.
This may seem surprising but may reﬂect the improved
quality of referrals from non-OSIs.
FVDR associated with non-OSI and OSI optometrists
The overall FVDR for referrals by a non-OSI was statistic-
ally signiﬁcantly higher than that for OSIs (particularly
the Manchester GRRS), suggesting superior concord-
ance of the OSI ﬁndings with the ﬁnal provider.
The lack of legal indemnity for optometrists not com-
plying with AOP’s recommendation interestingly has
proved to be a really effective way of changing optometry
practice, though unfortunately this directly resulted in
more inappropriate referrals.
The introduction of JCG did not lower FVDR in either
group, as would have been expected, with FVDRs
unchanged from the post-NICE period. This may be
because the undue perception of the importance of IOP
over other aspects of the ocular examination still
remained. However, the current practice FVDR in the
Manchester scheme did reduce to 3% from 16.9% in the
post-JCG time period, and may represent a delay in
the full implementation of JCG criteria by its participating
OSIs. Despite this for both OSIs and non-OSIs as a whole,
the highest FVDRs were in the current practice time
period, with the latter group reaching a statistical signiﬁ-
cant increase in FVDR compared with pre-NICE. This sug-
gests the need for further multistakeholder guidance
(such as the JCG) regarding detection and referral of sus-
pected glaucoma to be used in conjunction with the NICE
guidance on the diagnosis and management of glaucoma
and OHT. In addition, if AOP’s recommendation were
withdrawn, this may have a signiﬁcant impact on improv-
ing the quality of referrals and therefore lowering FVDR.
The lower IOP threshold for referral to ophthalmol-
ogy recommended in the NICE guidelines may explain
the rise in FVDR for the OSI post-NICE, but also may
reﬂect a culture by optometrists, OSI and non-OSI, to
adopt a more risk-averse approach to the clinical assess-
ment of patients with suspected glaucoma with a lower
threshold for referral in keeping with AOP’s recommen-
dation. This is speculative, but the maintenance of
FVDR in the post-JCG and current practice periods, with
the exception of Manchester, imply that whatever factors
caused the increase in ﬁrst-visit discharges post-NICE
remained there for the duration of this analysis.
Features of the ocular examination performed at the
referral refinement consultation that best predict a
diagnosis of glaucoma
The width-adjusted bar graphs of outcome of referral
based on reason for referral (ﬁgure 2) demonstrates the
large proportion of IOP-only referrals and its low diag-
nostic yield. In the referrals by a non-OSI, only 16.5% of
these patients were given a follow-up appointment, with
just 3.5% diagnosed with primary open angle glaucoma.
These values were considerably higher for the
OSI-initiated referrals (45% and 14.7%, respectively).
These ﬁndings highlight that IOP-only referrals repre-
sent a waste of hospital outpatient resource. However,
14.7% of these IOP-only referrals by OSIs were subse-
quently diagnosed with glaucoma. This implies either
the OSI had missed glaucomatous optic disc pathology,
or the extra expertise of the consultant ophthalmologist
assisted by additional imaging modalities available in the
hospital was able to identify the optic disc pathology.
In total, 79.7% of OSI referrals compared with only
49.4% of non-OSI referrals for solely a suspicious optic
disc appearance were followed up by the hospital, which
suggests, the extra training received by OSIs resulted in
more accurate referrals. However, the percentage of
patients actually diagnosed with glaucoma at the hospital
eye service was low in both OSI and non-OSI, 5.8% and
9%, respectively. This demonstrates that the consultant
ophthalmologist classiﬁed the majority of these referrals
as glaucoma suspect.
Multiple criterion referrals by OSI, such as an abnor-
mal IOP, optic disc and VF, resulted in a higher percent-
age of patients being diagnosed with glaucoma, 45.7%.
This leads the authors to question the effectiveness of
OSI in such referrals as a substantial proportion will be
subsequently referred to secondary care. The scheme in
Huntingdon has adopted risk stratiﬁcation through a
paper triage of the referrals by a non-OSI carried out by
the hospital, with only patients found to have one risk
factor deemed low risk and therefore suitable for glau-
coma referral reﬁnement. Our ﬁndings would suggest
that the stratiﬁcation of the referral letter according to
risk, a strategy that could be incorporated across all
medical specialties, could be an effective method to
ensure patients with a high probability of having glau-
coma are seen directly by secondary care without the
need for the additional examination by an OSI. This is
reﬂected by the most recent glaucoma publication from
NICE in March 2012: The NICE commissioners guide
‘services for people at risk of developing glaucoma’
which was produced to provide commissioners of eye
services guidance as to how to safely and effectively
manage patients at risk of glaucoma.29 It recommends
that patients with an IOP of greater than 30 mm Hg
should be referred directly to secondary care.
Limitations
There are some limitations of this study which are
important to consider. The false-negative rate, or per-
centage of patients who were inappropriately discharged
by non-OSIs and OSIs, is not known. This will be
addressed in an upcoming prospective study using the
recommendations of this report.
The ﬁnal provider in the schemes was not always a
consultant ophthalmologist, and therefore a reference
standard could not be applied across all the schemes
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that were evaluated. Again this will be addressed in the
upcoming prospective study.
OSIs are not performing opportunistic screening and
therefore their referrals are more likely to be appropriate
compared with non-OSIs. However, FVDR is the most
appropriate metric to measure the ‘added diagnostic
value’ an OSI introduces to the referral pathway in GRRS
compared with the traditional referral pathway in which a
non-OSI directly refers to the hospital eye service.
The time series for the study was carefully selected to
encompass all the major changes in clinical guidelines
and practice since 2009. However, by deﬁnition a retro-
spective observational time series study will not provide
data on all time points.
Recommendations
This report of activity from four established referral
reﬁnement schemes of differing design has highlighted
a continually increasing FVDR post-NICE. This study has
also demonstrated that specialist trained optometrists
(OSIs) can successfully reﬁne the referrals from
non-OSIs for suspected glaucoma leading to a statistic-
ally signiﬁcant reduction in FVDR. It is the authors’ rec-
ommendation that patients with a high chance of being
diagnosed with glaucoma based on the examination
ﬁndings of the non-OSI should be referred directly to
secondary care and those at lower risk could effectively
be reviewed by an OSI carrying out a comprehensive eye
examination. The results of this analysis lead us to rec-
ommend that ‘low risk’ should be deﬁned as referrals
based on IOP only, optic disc only, VF only and IOP and
VF, with all other referrals including any reference to a
shallow anterior chamber angle better suited to a direct
referral to secondary care.
The inclusion of VF and disc examination is clearly
associated with a lower FVDR and, therefore, the
authors recommend that detailed disc and VF examin-
ation form part of the referral reﬁnement in conjunc-
tion with Goldmann/Perkins tonometry for measuring
IOP. Using the referral criteria of the 2009 JCG crucially
allows the optometrist to operate within a professional
and legal framework, and can lower FVDR as shown by
the Manchester GRRS in the current practice time
frame.
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